biote (NASDAQ:BTMDW) Shares Down 1.7%

biote Corp. (NASDAQ:BTMDW) fell 1.7% during mid-day trading on Thursday . The stock traded as low as $1.19 and last traded at $1.19. 2,983 shares traded hands during trading, a decline of 95% from the average session volume of 58,814 shares. The stock had previously closed at $1.21.

biote Price Performance

The stock’s fifty day simple moving average is $1.39 and its 200-day simple moving average is $1.03.

Insider Activity

In related news, General Counsel Mary Elizabeth Conlon sold 6,240 shares of the firm’s stock in a transaction that occurred on Wednesday, July 5th. The shares were sold at an average price of $6.50, for a total transaction of $40,560.00. Following the sale, the general counsel now owns 140,393 shares in the company, valued at $912,554.50. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.

Hedge Funds Weigh In On biote

Hedge funds have recently made changes to their positions in the stock. Diametric Capital LP acquired a new position in shares of biote in the 4th quarter valued at $60,000. Jefferies Financial Group Inc. purchased a new position in shares of biote in the 4th quarter valued at $75,000. Finally, Meteora Capital LLC raised its stake in shares of biote by 3,889.3% in the 4th quarter. Meteora Capital LLC now owns 461,278 shares of the company’s stock valued at $138,000 after acquiring an additional 449,715 shares during the period.

biote Company Profile

biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements.